Nobi's smart light technology secures €35M Series B funding, co-led by Angelini Ventures 1/28/2025 Category: INVESTMENTS
Angelini Ventures co-leads €20M Series A in Neumirna to pioneer RNA therapies for neurological diseases 1/9/2025 Category: INVESTMENTS
Damona Pharmaceuticals receives FDA clearance to initiate Phase 1 clinical trial for innovative brain disorder treatment 11/6/2024 Category: PORTFOLIO NEWS
Angelini Ventures contributes to the new Angelini Industries ESG Strategy 2024-2026 11/6/2024 Category: SUSTAINABILITY
Lola Buono, Associate at Angelini Ventures, shares industry expertise on Radio 24's podcast 10/25/2024 Category: FEATURED IN
Biotech Insights: our Medical Director discusses healthcare strategies on BiotechTV 10/21/2024 Category: FEATURED IN
Angelini Ventures